Dr. Bouldin is Avid Author & Publisher! 7 ISBN: International Publications & 28 PubMed-NCBI Public Citations, & MORE ON THE WAY! IV NTR3...

Dear Dr Jay Bouldin, BSc, MSc, MBBS/MD, PHD'22, We acknowledge receipt of your outsourcing facility registration information submitted...

FDA-IND (INVESTIGATIONAL NEW DRUG) EXPANDED ACCESS "COMPASSIONATE USE" SUBMISSION 2022 BOTH FORMULAS CONTAIN INDIVIDUAL ORGANIC COMOUND...